GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinew Pharma Inc (ROCO:6634) » Definitions » Market Cap

Sinew Pharma (ROCO:6634) Market Cap : NT$3,495.37 Mil (As of Dec. 14, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Sinew Pharma Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sinew Pharma's share price for the quarter that ended in Jun. 2024 was NT$67.9. Sinew Pharma's Shares Outstanding (EOP) for the quarter that ended in Jun. 2024 was 71.33 Mil. Therefore, Sinew Pharma's market cap for the quarter that ended in Jun. 2024 was NT$4,843.58 Mil.

Sinew Pharma's quarterly market cap declined from Dec. 2022 (NT$7,360.95 Mil) to Jun. 2023 (NT$5,595.38 Mil) and declined from Jun. 2023 (NT$5,595.38 Mil) to Jun. 2024 (NT$4,843.58 Mil).

Sinew Pharma's annual market cap increased from Dec. 2020 (NT$4,821.14 Mil) to Dec. 2021 (NT$5,658.72 Mil) and increased from Dec. 2021 (NT$5,658.72 Mil) to Dec. 2022 (NT$7,360.95 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sinew Pharma's Enterprise Value for Today is NT$2,288.81 Mil.


Sinew Pharma Market Cap Historical Data

The historical data trend for Sinew Pharma's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinew Pharma Market Cap Chart

Sinew Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Market Cap
Get a 7-Day Free Trial Premium Member Only 530.18 965.67 4,821.14 5,658.72 7,360.95

Sinew Pharma Semi-Annual Data
Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Jun24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5,658.72 5,745.11 7,360.95 5,595.38 4,843.58

Competitive Comparison of Sinew Pharma's Market Cap

For the Biotechnology subindustry, Sinew Pharma's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinew Pharma's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sinew Pharma's Market Cap distribution charts can be found below:

* The bar in red indicates where Sinew Pharma's Market Cap falls into.



Sinew Pharma Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Sinew Pharma's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )=Share Price (A: Dec. 2022 )*Shares Outstanding (EOP) (A: Dec. 2022 )
=NT$105.5*69.772
=NT$7,360.95

Sinew Pharma's Market Cap for the quarter that ended in Jun. 2024 is calculated as

Market Cap (Q: Jun. 2024 )=Share Price (Q: Jun. 2024 )*Shares Outstanding (EOP) (Q: Jun. 2024 )
=NT$67.9*71.334
=NT$4,843.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinew Pharma  (ROCO:6634) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Sinew Pharma Market Cap Related Terms

Thank you for viewing the detailed overview of Sinew Pharma's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinew Pharma Business Description

Traded in Other Exchanges
N/A
Address
C516, Building C, Number 99, Lane 130, Section 1, Xueyin Road, Nangang District, Taipei, TWN, 11571
Sinew Pharma Inc is a Taiwan-based biopharmaceutical company. The company is mainly engaged in the research and development of new drugs for the treatment of liver diseases and pain relief. Its drug candidates includes SNP-610, SNP-630, SNP-810, SNP-820, SNP-830 and SNP-840.

Sinew Pharma Headlines

No Headlines